$OSIP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSI PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OSI PHARMACEUTICALS INC. Get notifications about new insider transactions in OSI PHARMACEUTICALS INC for free.
Page: < prev 1 ... 8 9 10 11 12 13 14 15 16 ... 19 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 64.25 | 1,848 | 118,734 | 12,649 | 14.5 K to 12.6 K (-12.75 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 64.21 | 35 | 2,247 | 14,497 | 14.5 K to 14.5 K (-0.24 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Sell | S | 64.20 | 138 | 8,860 | 14,532 | 14.7 K to 14.5 K (-0.94 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP,/Pres., On ... | Buy | M | 23.85 | 3,700 | 88,245 | 14,670 | 11 K to 14.7 K (+33.73 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Option Exercise | M | 30.74 | 1,423 | 43,743 | 16,229 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Option Exercise | M | 21.55 | 577 | 12,434 | 4,031 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 64.83 | 124 | 8,039 | 0 | 124 to 0 (-100.00 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 64.60 | 131 | 8,463 | 124 | 255 to 124 (-51.37 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 64.54 | 14 | 904 | 255 | 269 to 255 (-5.20 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 64.53 | 14 | 903 | 269 | 283 to 269 (-4.95 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 64.52 | 55 | 3,549 | 283 | 338 to 283 (-16.27 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 64.49 | 35 | 2,257 | 338 | 373 to 338 (-9.38 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 64.40 | 28 | 1,803 | 373 | 401 to 373 (-6.98 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 64.32 | 21 | 1,351 | 401 | 422 to 401 (-4.98 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 64.31 | 14 | 900 | 422 | 436 to 422 (-3.21 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 64.30 | 525 | 33,758 | 436 | 961 to 436 (-54.63 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 64.25 | 867 | 55,705 | 961 | 1.8 K to 961 (-47.43 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 64.21 | 34 | 2,183 | 1,828 | 1.9 K to 1.8 K (-1.83 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Sell | S | 64.20 | 138 | 8,860 | 1,862 | 2 K to 1.9 K (-6.90 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Buy | M | 30.74 | 1,423 | 43,743 | 2,000 | 577 to 2 K (+246.62 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WOOD BARBARA A | V.P. & General Coun ... | Buy | M | 21.55 | 577 | 12,434 | 577 | 0 to 577 |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 45.01 | 3,400 | 153,034 | 123,200 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 30.74 | 2,300 | 70,702 | 43,700 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Option Exercise | M | 21.55 | 798 | 17,197 | 5,574 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 65.00 | 3,400 | 221,000 | 4,255 | 7.7 K to 4.3 K (-44.42 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 64.83 | 193 | 12,512 | 7,655 | 7.8 K to 7.7 K (-2.46 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 64.60 | 203 | 13,114 | 7,848 | 8.1 K to 7.8 K (-2.52 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 64.54 | 21 | 1,355 | 8,051 | 8.1 K to 8.1 K (-0.26 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 64.53 | 21 | 1,355 | 8,072 | 8.1 K to 8.1 K (-0.26 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 64.52 | 86 | 5,549 | 8,093 | 8.2 K to 8.1 K (-1.05 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 64.49 | 54 | 3,482 | 8,179 | 8.2 K to 8.2 K (-0.66 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 64.40 | 43 | 2,769 | 8,233 | 8.3 K to 8.2 K (-0.52 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 64.32 | 32 | 2,058 | 8,276 | 8.3 K to 8.3 K (-0.39 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 64.31 | 21 | 1,351 | 8,308 | 8.3 K to 8.3 K (-0.25 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 64.30 | 813 | 52,276 | 8,329 | 9.1 K to 8.3 K (-8.89 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 64.25 | 1,343 | 86,288 | 9,142 | 10.5 K to 9.1 K (-12.81 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 64.21 | 54 | 3,467 | 10,485 | 10.5 K to 10.5 K (-0.51 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Sell | S | 64.20 | 214 | 13,739 | 10,539 | 10.8 K to 10.5 K (-1.99 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Buy | M | 45.01 | 3,400 | 153,034 | 10,753 | 7.4 K to 10.8 K (+46.24 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Buy | M | 30.74 | 2,300 | 70,702 | 7,353 | 5.1 K to 7.4 K (+45.52 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | ONETTO NICOLE | Exec.VP& Chief Medi ... | Buy | M | 21.55 | 798 | 17,197 | 5,053 | 4.3 K to 5.1 K (+18.75 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 6.88 | 700 | 4,813 | 49,300 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Option Exercise | M | 5.25 | 7,650 | 40,163 | 0 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.83 | 520 | 33,712 | 34,199 | 34.7 K to 34.2 K (-1.50 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.60 | 548 | 35,401 | 34,719 | 35.3 K to 34.7 K (-1.55 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.54 | 57 | 3,679 | 35,267 | 35.3 K to 35.3 K (-0.16 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.53 | 57 | 3,678 | 35,324 | 35.4 K to 35.3 K (-0.16 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.52 | 231 | 14,904 | 35,381 | 35.6 K to 35.4 K (-0.65 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.49 | 144 | 9,287 | 35,612 | 35.8 K to 35.6 K (-0.40 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.40 | 115 | 7,406 | 35,756 | 35.9 K to 35.8 K (-0.32 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.32 | 87 | 5,596 | 35,871 | 36 K to 35.9 K (-0.24 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.31 | 58 | 3,730 | 35,958 | 36 K to 36 K (-0.16 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.30 | 2,193 | 141,010 | 36,016 | 38.2 K to 36 K (-5.74 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.25 | 3,619 | 232,521 | 38,209 | 41.8 K to 38.2 K (-8.65 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.21 | 144 | 9,246 | 41,828 | 42 K to 41.8 K (-0.34 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Sell | S | 64.20 | 577 | 37,043 | 41,972 | 42.5 K to 42 K (-1.36 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 6.88 | 700 | 4,813 | 42,549 | 41.8 K to 42.5 K (+1.67 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GODDARD COLIN | Chief Executive Off ... | Buy | M | 5.25 | 7,650 | 40,163 | 41,849 | 34.2 K to 41.8 K (+22.37 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Option Exercise | M | 30.74 | 528 | 16,231 | 13,444 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Option Exercise | M | 21.55 | 467 | 10,064 | 3,261 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 64.83 | 62 | 4,019 | 0 | 62 to 0 (-100.00 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 64.60 | 65 | 4,199 | 62 | 127 to 62 (-51.18 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 64.54 | 7 | 452 | 127 | 134 to 127 (-5.22 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 64.53 | 7 | 452 | 134 | 141 to 134 (-4.96 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 64.52 | 28 | 1,807 | 141 | 169 to 141 (-16.57 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 64.49 | 16 | 1,032 | 169 | 185 to 169 (-8.65 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 64.40 | 15 | 966 | 185 | 200 to 185 (-7.50 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 64.32 | 10 | 643 | 200 | 210 to 200 (-4.76 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 64.31 | 7 | 450 | 210 | 217 to 210 (-3.23 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 64.30 | 261 | 16,782 | 217 | 478 to 217 (-54.60 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 64.25 | 431 | 27,692 | 478 | 909 to 478 (-47.41 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 64.21 | 17 | 1,092 | 909 | 926 to 909 (-1.84 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Sell | S | 64.20 | 69 | 4,430 | 926 | 995 to 926 (-6.93 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Buy | M | 30.74 | 528 | 16,231 | 995 | 467 to 995 (+113.06 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | AMPER LINDA E | VP Bus. Administrat ... | Buy | M | 21.55 | 467 | 10,064 | 467 | 0 to 467 |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 6.50 | 2,917 | 18,961 | 29,166 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.83 | 181 | 11,734 | 5,577 | 5.8 K to 5.6 K (-3.14 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.60 | 193 | 12,468 | 5,758 | 6 K to 5.8 K (-3.24 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.54 | 20 | 1,291 | 5,951 | 6 K to 6 K (-0.33 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.53 | 20 | 1,291 | 5,971 | 6 K to 6 K (-0.33 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.52 | 81 | 5,226 | 5,991 | 6.1 K to 6 K (-1.33 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.49 | 50 | 3,225 | 6,072 | 6.1 K to 6.1 K (-0.82 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.40 | 40 | 2,576 | 6,122 | 6.2 K to 6.1 K (-0.65 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.32 | 30 | 1,930 | 6,162 | 6.2 K to 6.2 K (-0.48 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.31 | 20 | 1,286 | 6,192 | 6.2 K to 6.2 K (-0.32 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.30 | 766 | 49,254 | 6,212 | 7 K to 6.2 K (-10.98 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.25 | 1,264 | 81,212 | 6,978 | 8.2 K to 7 K (-15.34 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.21 | 50 | 3,211 | 8,242 | 8.3 K to 8.2 K (-0.60 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.20 | 202 | 12,968 | 8,292 | 8.5 K to 8.3 K (-2.38 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 6.50 | 2,917 | 18,961 | 8,494 | 5.6 K to 8.5 K (+52.30 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Option Exercise | M | 6.50 | 2,917 | 18,961 | 29,166 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.83 | 181 | 11,734 | 5,577 | 5.8 K to 5.6 K (-3.14 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.60 | 193 | 12,468 | 5,758 | 6 K to 5.8 K (-3.24 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.54 | 20 | 1,291 | 5,951 | 6 K to 6 K (-0.33 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.53 | 20 | 1,291 | 5,971 | 6 K to 6 K (-0.33 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.52 | 81 | 5,226 | 5,991 | 6.1 K to 6 K (-1.33 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.49 | 50 | 3,225 | 6,072 | 6.1 K to 6.1 K (-0.82 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.40 | 40 | 2,576 | 6,122 | 6.2 K to 6.1 K (-0.65 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.32 | 30 | 1,930 | 6,162 | 6.2 K to 6.2 K (-0.48 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.31 | 20 | 1,286 | 6,192 | 6.2 K to 6.2 K (-0.32 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.30 | 766 | 49,254 | 6,212 | 7 K to 6.2 K (-10.98 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.25 | 1,264 | 81,212 | 6,978 | 8.2 K to 7 K (-15.34 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.21 | 50 | 3,211 | 8,242 | 8.3 K to 8.2 K (-0.60 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Sell | S | 64.20 | 202 | 12,968 | 8,292 | 8.5 K to 8.3 K (-2.38 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | GRANNER DARYL K | Director | Buy | M | 6.50 | 2,917 | 18,961 | 8,494 | 5.6 K to 8.5 K (+52.30 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Option Exercise | M | 9.25 | 1,667 | 15,420 | 16,666 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 64.83 | 104 | 6,742 | 8,052 | 8.2 K to 8.1 K (-1.28 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 64.60 | 108 | 6,977 | 8,156 | 8.3 K to 8.2 K (-1.31 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 64.54 | 12 | 774 | 8,264 | 8.3 K to 8.3 K (-0.14 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 64.53 | 12 | 774 | 8,276 | 8.3 K to 8.3 K (-0.14 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 64.52 | 46 | 2,968 | 8,288 | 8.3 K to 8.3 K (-0.55 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 64.49 | 29 | 1,870 | 8,334 | 8.4 K to 8.3 K (-0.35 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 64.40 | 23 | 1,481 | 8,363 | 8.4 K to 8.4 K (-0.27 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 64.32 | 17 | 1,093 | 8,386 | 8.4 K to 8.4 K (-0.20 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 64.31 | 12 | 772 | 8,403 | 8.4 K to 8.4 K (-0.14 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 64.30 | 438 | 28,163 | 8,415 | 8.9 K to 8.4 K (-4.95 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 64.25 | 722 | 46,389 | 8,853 | 9.6 K to 8.9 K (-7.54 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 64.21 | 29 | 1,862 | 9,575 | 9.6 K to 9.6 K (-0.30 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Sell | S | 64.20 | 115 | 7,383 | 9,604 | 9.7 K to 9.6 K (-1.18 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | LOVENBERG WALTER M PHD | Director | Buy | M | 9.25 | 1,667 | 15,420 | 9,719 | 8.1 K to 9.7 K (+20.70 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 7.09 | 2,750 | 19,509 | 8,405 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.83 | 171 | 11,086 | 4,766 | 4.9 K to 4.8 K (-3.46 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.60 | 181 | 11,693 | 4,937 | 5.1 K to 4.9 K (-3.54 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.54 | 19 | 1,226 | 5,118 | 5.1 K to 5.1 K (-0.37 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.53 | 19 | 1,226 | 5,137 | 5.2 K to 5.1 K (-0.37 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.52 | 75 | 4,839 | 5,156 | 5.2 K to 5.2 K (-1.43 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.49 | 48 | 3,096 | 5,231 | 5.3 K to 5.2 K (-0.91 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.40 | 38 | 2,447 | 5,279 | 5.3 K to 5.3 K (-0.71 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.32 | 29 | 1,865 | 5,317 | 5.3 K to 5.3 K (-0.54 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.31 | 18 | 1,158 | 5,346 | 5.4 K to 5.3 K (-0.34 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.30 | 722 | 46,425 | 5,364 | 6.1 K to 5.4 K (-11.86 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.25 | 1,192 | 76,586 | 6,086 | 7.3 K to 6.1 K (-16.38 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.21 | 48 | 3,082 | 7,278 | 7.3 K to 7.3 K (-0.66 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 64.20 | 190 | 12,198 | 7,326 | 7.5 K to 7.3 K (-2.53 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 7.09 | 2,750 | 19,509 | 7,516 | 4.8 K to 7.5 K (+57.70 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Option Exercise | M | 9.25 | 4,167 | 38,545 | 7,499 | |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.83 | 321 | 20,810 | 19,890 | 20.2 K to 19.9 K (-1.59 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.60 | 339 | 21,899 | 20,211 | 20.6 K to 20.2 K (-1.65 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.54 | 36 | 2,323 | 20,550 | 20.6 K to 20.6 K (-0.17 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.53 | 36 | 2,323 | 20,586 | 20.6 K to 20.6 K (-0.17 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.52 | 143 | 9,226 | 20,622 | 20.8 K to 20.6 K (-0.69 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.49 | 89 | 5,740 | 20,765 | 20.9 K to 20.8 K (-0.43 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.40 | 70 | 4,508 | 20,854 | 20.9 K to 20.9 K (-0.33 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.32 | 55 | 3,538 | 20,924 | 21 K to 20.9 K (-0.26 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.31 | 36 | 2,315 | 20,979 | 21 K to 21 K (-0.17 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.30 | 1,357 | 87,255 | 21,015 | 22.4 K to 21 K (-6.07 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.25 | 2,239 | 143,856 | 22,372 | 24.6 K to 22.4 K (-9.10 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.21 | 89 | 5,715 | 24,611 | 24.7 K to 24.6 K (-0.36 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Sell | S | 64.20 | 357 | 22,919 | 24,700 | 25.1 K to 24.7 K (-1.42 %) |
Nov 02 2004 | OSIP | OSI PHARMACEUTICAL ... | WHITE JOHN P | Director | Buy | M | 9.25 | 4,167 | 38,545 | 25,057 | 20.9 K to 25.1 K (+19.95 %) |